estimateR: an R package to estimate and monitor the effective reproductive number.

COVID-19 Effective reproductive number Epidemiology Monitoring Outbreak R package Re Rt Surveillance

Journal

BMC bioinformatics
ISSN: 1471-2105
Titre abrégé: BMC Bioinformatics
Pays: England
ID NLM: 100965194

Informations de publication

Date de publication:
11 Aug 2023
Historique:
received: 28 06 2022
accepted: 24 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 11 8 2023
Statut: epublish

Résumé

Accurate estimation of the effective reproductive number ([Formula: see text]) of epidemic outbreaks is of central relevance to public health policy and decision making. We present estimateR, an R package for the estimation of the reproductive number through time from delayed observations of infection events. Such delayed observations include confirmed cases, hospitalizations or deaths. The package implements the methodology of Huisman et al. but modularizes the [Formula: see text] estimation procedure to allow easy implementation of new alternatives to the currently available methods. Users can tailor their analyses according to their particular use case by choosing among implemented options. The estimateR R package allows users to estimate the effective reproductive number of an epidemic outbreak based on observed cases, hospitalization, death or any other type of event documenting past infections, in a fast and timely fashion. We validated the implementation with a simulation study: estimateR yielded estimates comparable to alternative publicly available methods while being around two orders of magnitude faster. We then applied estimateR to empirical case-confirmation incidence data for COVID-19 in nine countries and for dengue fever in Brazil; in parallel, estimateR is already being applied (i) to SARS-CoV-2 measurements in wastewater data and (ii) to study influenza transmission based on wastewater and clinical data in other studies. In summary, this R package provides a fast and flexible implementation to estimate the effective reproductive number for various diseases and datasets. The estimateR R package is a modular and extendable tool designed for outbreak surveillance and retrospective outbreak investigation. It extends the method developed for COVID-19 by Huisman et al. and makes it available for a variety of pathogens, outbreak scenarios, and observation types. Estimates obtained with estimateR can be interpreted directly or used to inform more complex epidemic models (e.g. for forecasting) on the value of [Formula: see text].

Sections du résumé

BACKGROUND BACKGROUND
Accurate estimation of the effective reproductive number ([Formula: see text]) of epidemic outbreaks is of central relevance to public health policy and decision making. We present estimateR, an R package for the estimation of the reproductive number through time from delayed observations of infection events. Such delayed observations include confirmed cases, hospitalizations or deaths. The package implements the methodology of Huisman et al. but modularizes the [Formula: see text] estimation procedure to allow easy implementation of new alternatives to the currently available methods. Users can tailor their analyses according to their particular use case by choosing among implemented options.
RESULTS RESULTS
The estimateR R package allows users to estimate the effective reproductive number of an epidemic outbreak based on observed cases, hospitalization, death or any other type of event documenting past infections, in a fast and timely fashion. We validated the implementation with a simulation study: estimateR yielded estimates comparable to alternative publicly available methods while being around two orders of magnitude faster. We then applied estimateR to empirical case-confirmation incidence data for COVID-19 in nine countries and for dengue fever in Brazil; in parallel, estimateR is already being applied (i) to SARS-CoV-2 measurements in wastewater data and (ii) to study influenza transmission based on wastewater and clinical data in other studies. In summary, this R package provides a fast and flexible implementation to estimate the effective reproductive number for various diseases and datasets.
CONCLUSIONS CONCLUSIONS
The estimateR R package is a modular and extendable tool designed for outbreak surveillance and retrospective outbreak investigation. It extends the method developed for COVID-19 by Huisman et al. and makes it available for a variety of pathogens, outbreak scenarios, and observation types. Estimates obtained with estimateR can be interpreted directly or used to inform more complex epidemic models (e.g. for forecasting) on the value of [Formula: see text].

Identifiants

pubmed: 37568078
doi: 10.1186/s12859-023-05428-4
pii: 10.1186/s12859-023-05428-4
pmc: PMC10416499
doi:

Substances chimiques

Wastewater 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

310

Subventions

Organisme : Swiss National Science Foundation
ID : 31CA30 196267
Pays : Switzerland

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Am J Epidemiol. 2006 Sep 15;164(6):591-7
pubmed: 16887892
PLoS One. 2012;7(11):e50972
pubmed: 23226436
Swiss Med Wkly. 2020 May 04;150:w20271
pubmed: 32365217
Phys Rep. 2021 May 23;913:1-52
pubmed: 33612922
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Epidemics. 2019 Dec;29:100356
pubmed: 31624039
PLOS Digit Health. 2022 Jun 27;1(6):e0000052
pubmed: 36812522
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Eur J Epidemiol. 2011 Mar;26(3):195-201
pubmed: 21416274
PLoS Negl Trop Dis. 2017 Jul 19;11(7):e0005797
pubmed: 28723920
Stat Med. 2019 Sep 30;38(22):4363-4377
pubmed: 31292995
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21825-9
pubmed: 20080801
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Euro Surveill. 2022 Mar;27(10):
pubmed: 35272745
PLoS Comput Biol. 2020 Dec 10;16(12):e1008409
pubmed: 33301457
Environ Health Perspect. 2022 May;130(5):57011
pubmed: 35617001
Eur J Epidemiol. 2022 Oct;37(10):1003-1024
pubmed: 36152133
PLoS One. 2008 May 14;3(5):e2185
pubmed: 18478118
J Infect Dis. 2021 Sep 1;224(5):783-787
pubmed: 34086944
Elife. 2022 Aug 08;11:
pubmed: 35938911
Epidemics. 2018 Dec;25:101-111
pubmed: 29945778

Auteurs

Jérémie Scire (J)

Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology, Basel, Switzerland. scirejeremie@gmail.com.
Swiss Institute of Bioinformatics, Lausanne, Switzerland. scirejeremie@gmail.com.

Jana S Huisman (JS)

Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology, Basel, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Department of Environmental Systems Science, ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.
Department of Physics, Massachusetts Institute of Technology, Cambridge, USA.

Ana Grosu (A)

Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology, Basel, Switzerland.

Daniel C Angst (DC)

Department of Environmental Systems Science, ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.

Adrian Lison (A)

Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology, Basel, Switzerland.

Jinzhou Li (J)

Department of Mathematics, ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.

Marloes H Maathuis (MH)

Department of Mathematics, ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.

Sebastian Bonhoeffer (S)

Department of Environmental Systems Science, ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.

Tanja Stadler (T)

Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology, Basel, Switzerland. tanja.stadler@bsse.ethz.ch.
Swiss Institute of Bioinformatics, Lausanne, Switzerland. tanja.stadler@bsse.ethz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH